Ultra-rapid lispro is more protective against exercise-associated hypoglycaemia over lispro in adults with type 1 diabetes on continuous subcutaneous insulin infusion

被引：0
|
作者：
Leohr, J. [1 ]
Abibol, A. [2 ]
LaBell, E. Smith [1 ]
Ghosh, A. [1 ]
Turner, L. V. [3 ]
Shakeri, D. [3 ]
Fukuda, T. [1 ]
Riddell, M. C. [2 ,3 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] LMC Healthcare, Centr Res, Toronto, ON, Canada
[3] York Univ, Muscle Hlth Res Ctr, Toronto, ON, Canada
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [21] Focal vitiligo related to subcutaneous insulin lispro infusion in type 1 diabetes.
    Carey, JD
    Burge, MR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S143 - S143
  • [22] Efficacy and safety of ultra-rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO-Peds trial
    Wadwa, R. Paul
    Laffel, Lori M.
    Franco, Denise R.
    Dellva, Mary Anne
    Knights, Alastair W.
    Pollom, Robyn K.
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 89 - 97
  • [23] Insulin aspart versus insulin lispro via continuous subcutaneous insulin infusion (CSII) in children and adolescents with type 1 diabetes
    Weinzimer, Stuart
    Laffel, Lori
    Ternand, Christine
    Howard, Campbell
    Chang, C. T.
    Becker, Dorothy
    DIABETES, 2007, 56 : A478 - A478
  • [24] Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion - A randomized study in type 1 diabetes
    Bode, B
    Raskin, P
    Weinstein, R
    Davidson, J
    Bell, D
    Henry, R
    McGill, J
    Huang, WC
    Nadeau, D
    Reinhardt, RR
    DIABETES CARE, 2002, 25 (03) : 439 - 444
  • [25] Glycemic Control and Perinatal Outcomes of Pregnancies Complicated by Type 1 Diabetes: Influence of Continuous Subcutaneous Insulin Infusion and Lispro Insulin
    Chico, Ana
    Saigi, Ignasi
    Garcia-Patterson, Apolonia
    Dolores Santos, M.
    Adelantado, Juan M.
    Ginovart, Gemma
    de Leiva, Alberto
    Corcoy, Rosa
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (12) : 937 - 945
  • [26] Evaluation of Insulin Lispro Pharmacokinetics and Pharmacodynamics Over 10 Days of Continuous Insulin Infusion in People With Type 1 Diabetes
    Garhyan, Parag
    Pratt, Edward
    Famulla, Susanne
    Zijlstra, Eric
    Lalonde, Amy
    Swinney, Monica
    Kazda, Christof
    Klein, Oliver
    Dassau, Eyal
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2023, 17 (02): : 274 - 282
  • [27] A Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion of Insulin Aspart Versus Insulin Lispro in Children and Adolescents With Type 1 Diabetes
    Weinzimer, Stuart A.
    Ternand, Christine
    Howard, Campbell
    Chang, Cheng-Tao
    Becker, Dorothy J.
    Laffel, Lori M. B.
    DIABETES CARE, 2008, 31 (02) : 210 - 215
  • [28] Better Postprandial Glucose Stability During Continuous Subcutaneous Infusion with Insulin Aspart Compared with Insulin Lispro in Patients with Type 1 Diabetes
    Di Bartolo, Paolo
    Pellicano, Francesca
    Scaramuzza, Antonio
    Sardu, Cipriana
    Casetti, Tino
    Bosi, Emanuele
    Miselli, Valerio
    Brandolini, Sara
    Fabbri, Tiziano
    Meandri, Piero
    Cannata, Francesco
    DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (06) : 495 - 498
  • [29] Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes
    Andersen, Grit
    Meiffren, Gregory
    Lamers, Daniela
    DeVries, J. Hans
    Ranson, Aymeric
    Seroussi, Cyril
    Alluis, Bertrand
    Gaudier, Martin
    Soula, Olivier
    Heise, Tim
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2627 - 2632
  • [30] Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
    Malecki, Maciej T.
    Cao, Dachuang
    Liu, Rong
    Hardy, Thomas
    Bode, Bruce
    Bergenstal, Richard M.
    Bue-Valleskey, Juliana
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (11) : 853 - 860
12345